Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Legend Biotech Corporation, a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative cell therapies, particularly in the field of oncology.
With a focus on CAR-T cell therapies, Legend Biotech's flagship product, cilta-cel, has garnered significant attention for its unique approach to treating multiple myeloma. The company operates primarily in the US and has expanded its reach into key international markets, enhancing its global footprint.
Recognised for its commitment to advancing healthcare, Legend Biotech has achieved notable milestones, including strategic partnerships and successful clinical trials, solidifying its position as a trailblazer in the biopharmaceutical landscape.
+21 vs industry average
Legend Biotech’s score of 63 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Legend Biotech, a US-based pharmaceutical preparation manufacturer, reported its Scope 1 and 2 emissions for 2024. The company's market-based Scope 1 and 2 emissions totalled approximately 12,715,000 kg CO2e in 2024. This comprised about 769,000 kg CO2e from Scope 1 emissions and 11,945,000 kg CO2e from market-based Scope 2 emissions. For 2023, Legend Biotech's market-based Scope 1 and 2 emissions were approximately 12,973,530 kg CO2e, including around 770,000 kg CO2e from Scope 1 and 12,204,000 kg CO2e from market-based Scope 2 emissions.
As a current subsidiary of Legend Biotech Corporation, its environmental data is reported directly. The company has not yet disclosed Scope 3 emissions data. Legend Biotech has not publicly committed to any specific emissions reduction targets, such as those validated by the Science Based Targets initiative (SBTi).
No climate goals have been disclosed for Legend Biotech yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more